We are live on ! Find out more
CA

CHI Advisors Portfolio holdings

AUM $252M
1-Year Est. Return 56.99%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+56.99%
3 Year Est. Return
+88.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$26.7M
Cap. Flow
+$49.5M
Cap. Flow %
18.91%
Top 10 Hldgs %
82.76%
Holding
28
New
6
Increased
13
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
KZR
Kezar Life Sciences
KZR
+$13.5M
2
INZY
Inozyme Pharma
INZY
+$4.97M
3
NKTX icon
Nkarta
NKTX
+$4.7M
4
DTIL icon
Precision BioSciences
DTIL
+$4.69M
5
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$3.76M

Top Sells

Rank Stock Value
1
ONCR
Oncorus, Inc.
ONCR
+$67.9K

Sector Composition

Rank Sector Weight
1 Healthcare 99.85%
2 Miscellaneous 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
26
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$372K 0.14%
157,000
-65,500
-29% -$4.92M
KZR
27
CALL
DELISTED
Kezar Life Sciences
KZR
$5K ﹤0.01%
+10,000
New +$882K
EIGR
28
CALL
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4K ﹤0.01%
+837
New +$169K
1
2

Similar funds

SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
TOGEPT
Trustees of General Electric Pension Trust Norwalk, Connecticut $245M AUM 128.88% 1-Year Est. Return
IAM
Innovis Asset Management Chicago, Illinois $260M AUM 28.13% 1-Year Est. Return
RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return

CHI Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, CHI Advisors held 28 positions worth $262M, up 11% from $235M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

CHI Advisors deployed $49.5M of net new capital in Q2 2022, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was Nkarta: 358,013 shares worth $4.41M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was Oncorus, Inc., an estimated $67.9K trimmed.

  • CHI Advisors's largest Q2 2022 buy was Nkarta: 358,013 shares worth $4.41M.
  • CHI Advisors added most to Kezar Life Sciences in Q2 2022, an estimated $13.5M increase.
  • CHI Advisors's biggest Q2 2022 reduction was Oncorus, Inc., cutting an estimated $67.9K.
  • CHI Advisors's ten largest holdings make up 83% of its $262M portfolio in Q2 2022.
  • CHI Advisors opened 6 new positions and closed 0 in Q2 2022.
  • CHI Advisors's portfolio value rose 11% quarter-over-quarter to $262M.

Based on CHI Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.